Welcome to LookChem.com Sign In|Join Free
  • or
(Z)-1-methoxy-4-[2-(3-nitrophenyl)ethenyl]benzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

17555-96-3

Post Buying Request

17555-96-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17555-96-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 17555-96-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,5,5 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 17555-96:
(7*1)+(6*7)+(5*5)+(4*5)+(3*5)+(2*9)+(1*6)=133
133 % 10 = 3
So 17555-96-3 is a valid CAS Registry Number.

17555-96-3Relevant academic research and scientific papers

Microwave-assisted wittig reaction of semistabilized nitro-substituted benzyltriphenyl-phosphorous ylides with aldehydes in phase-transfer conditions

Rodrigues, Tiago,Lopes, Francisca,Moreira, Rui

experimental part, p. 747 - 755 (2011/12/15)

We report here a simple entry into the nitrostilbene system in very short reaction times and good yields using the microwave-assisted Wittig reaction in phase-transfer conditions of nitro-substituted benzyltriphenylphosphonium ylides with aldehydes. Taylor & Francis Group, LLC.

Separation of α-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRα-selective antagonists

Motoshima, Kazunori,Noguchi-Yachide, Tomomi,Sugita, Kazuyuki,Hashimoto, Yuichi,Ishikawa, Minoru

experimental part, p. 5001 - 5014 (2009/12/24)

Liver X receptor (LXR) α/β dual agonists are candidate medicaments for the treatment of metabolic syndrome, because their biological actions include increasing cholesterol efflux mediated by LXRβ. However, their clinical application is currently limited by their enhancing effect on triglyceride (TG) synthesis mediated by LXRα. Combination of an LXRα-selective antagonist with an LXRα/β dual agonist may overcome this disadvantage. In the present work, structural development studies of phenethylphenyl phthalimide 9, which possesses LXRα/β dual-antagonistic activity and α-glucosidase-inhibitory activity, led to the LXRα-selective antagonist 23f. Specific α-glucosidase inhibitors were also obtained.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 17555-96-3